JW
Publicaties op Oncologisch.com
Neoadjuvant trastuzumab deruxtecan alone or followed by paclitaxel, trastuzumab, and pertuzumab for high-risk HER2-po...
Efficacy and safety of neoadjuvant SHR-A1811 with or without pyrotinib in women with locally gevorderd or early HER2-...
Belzutifan dosisoptimalisatie bij heldercellig RCC: LITESPARK-013 fase II
Biomarkers in CBCSG006: cisplatine plus gemcitabine bij TNBC